Safety Profile
The most commonly reported adverse reactions were upper respiratory tract infection (18.9%), headache (18.3%) and diarrhoea (11.0%). The most commonly reported serious adverse reaction was urinary tract infection (1.2%) 1 .
- Twitter Linkedin Facebook Pinterest Google plus
Safety profile
Safety Profile - Entresto
ENTRESTO ® demonstrated comparable safety and tolerability vs EnalaprilTwitter Linkedin Facebook Pinterest Google plusSafety Profile - Scemblix
Below is a selection of the observed side effects. Please refer to the SmPc for the complete list.
The most common adverse reactions of any grade (incidence ≥20%) in patients receiving asciminib were musculoskeletal pain (37.1%), upper...Twitter Linkedin Facebook Pinterest Google plusSafety Profile - Kesimpta
Safety Profile
As with every medicine, when using REVOLADE, side effects can occur. In the case of serious side effects, it is possible that a dose adjustment is necessary. See also the Summary of Product Characteristics for a full overview of the side effects and side...Twitter Linkedin Facebook Pinterest Google plusSafety Profile - Jakavi
Below is a selection of the observed side effects; please refer to the SmPc or the package leaflet for the complete list.
Myelosuppression
Patients who develop anaemia may need blood transfusions. Dose adjustment or...Twitter Linkedin Facebook Pinterest Google plusSafety Profile
Safety profile - Cosentyx PsA
Safety profile